President to confer national award to 11 children Monday
New Delhi (PTI): President Droupadi Murmu on Monday will confer the Pradhan Mantri Rashtriya Bal Puraskar (PMRBP) 2023 on 11 children for their exceptional achievements.
Prime Minister Narendra Modi will interact with the awardees on Tuesday.
Minister of Women and Child Development Smriti Zubin Irani will also interact with the children and congratulate them in the presence of Minister of State for Women and Child Development Munjpara Mahendrabhai, according to an official statement.
There are six boys and five girls among the awardees from 11 states and UTs
Each awardee of the PMRBP will be given a medal, a cash prize of Rs 1 Lakh and a certificate.
The Union government the PMRBP award to children for their exceptional achievements. The award is conferred on children in the age group 5-18 for their excellence in six categories, viz art and culture, bravery, innovation, scholastic, social service and sports, which deserve national recognition.
This year, the Pradhan Mantri Rashtriya Bal Puraskar will be conferred on 11 children selected from all regions of the country for their exceptional achievement in the field of art and culture (4), bravery (1), innovation (2), social service (1), and sports (3), the statement said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ballari maternal deaths: Karnataka govt. seeks explanation from CDSCO
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.
